Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.
Journal Information
Full Title: BMC Urol
Abbreviation: BMC Urol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateEthical approval was first given by the Monash University’s ethical committee and consecutively at each participating institution within the True North Global Registry. Patients had to give written informed consent to participate in all countries except for the following local data centers, where inclusion was based on an opt-out-approach for either clinical data and/or PROMs at some of their sites (in brackets, the name of the ethics committee/institutional review board that waived off the informed consent): Australian Prostate Cancer Research Centre—PCOR-QLD (Metro South Human Research Ethics Committee); Prostate Cancer Outcomes Registry Victoria, Australia—PCOR-VIC (The Alfred Ethics Committee, Australia Urology Associates); University Health Network, Canada (University Health Network Research Ethics Board, The University of British Columbia Clinical Research Ethics Board, Health Research Ethics Board of Alberta – Cancer Committee); Center for Health Outcome Measures, New Zealand (Ministry of Health—Health and Disability Ethics Committee); and Santeon, The Netherlands (Medical Research Ethics Committees United).The study was conducted in accordance with the ethical standards of the institutional research committees and the 2000 revision of the Declaration of Helsinki. Consent for publicationNot applicable. Competing interestsThe following author is employed by the sponsor: PV. All other authors declare that there is no conflict of interest. Competing interests The following author is employed by the sponsor: PV. All other authors declare that there is no conflict of interest."
" Funding Agency: Sibilah Breen 10 , Silvi Brglevska 10 and Michelle King 10 Funding Financial support for this study was provided in part by a contract with the non-profit Movember Foundation. The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. Projects PI21/00023, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, and PI13/00412, funded by Instituto de Salud Carlos III (ISCIII)-FEDER, also supported this study.VZ’s contract is funded by the pre-doctoral training in health research grant ISCIII-FSE FI19/00229. OG, VZ, MF and AP are partly funded by AGAUR 2021 SGR 00624 and CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III CB06/02/0046."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025